We’re accepting orders by email. To place an order, email support@myfreedompeptides.com with the product, strength, and quantity you’d like.

For research use only. Not for human or veterinary use. Supplied as a lyophilized powder for laboratory research.

Ipamorelin research dates to a 1998 paper that described it as “the first selective growth hormone secretagogue” [1]. Ipamorelin is a synthetic pentapeptide identified in a chemistry program built on growth hormone-releasing peptides (GHRPs). In rat pituitary cells it released growth hormone (GH) with potency and efficacy similar to GHRP-6, acting through a GHRP-like receptor [1]. Its selectivity is what distinguished it: in swine, ipamorelin did not raise ACTH or cortisol above the levels seen with GHRH, unlike GHRP-6 and GHRP-2 [1].

What is ipamorelin? Structure

PropertyValue
TypeSynthetic pentapeptide GH secretagogue [1]
SequenceAib-His-D-2-Nal-D-Phe-Lys-NH₂ [1]
Formula / MWC₃₈H₄₉N₉O₅ / ~711.9 g/mol (PubChem CID 9831659)
ReceptorGHRP-like receptor [1]
Form supplied by MFPSupplied as a lyophilized powder for laboratory research

Ipamorelin studies: key findings

From the 1998 discovery paper [1]:

A 1999 rat study reported increases in longitudinal bone growth rate with ipamorelin, without changes in total IGF-I, IGF-binding proteins or serum bone markers [2].

Ipamorelin vs other GH secretagogues

IpamorelinGHRP-6 / GHRP-2CJC-1295
ClassGHRP-receptor agonist [1]GHRP-receptor agonists [1]GHRH analog
ACTH/cortisol in swineNot significantly raised [1]Raised [1]Not compared in [1]
Related article——CJC-1295 With vs Without DAC

Regulatory status

FDA lists ipamorelin acetate in Category 2 of bulk drug substances nominated for compounding that may present significant safety risks [3]. Ipamorelin is not FDA-approved for any use.

Frequently asked questions

What is ipamorelin?

A synthetic pentapeptide growth hormone secretagogue that acts through a GHRP-like receptor [1].

Why is ipamorelin called selective?

In swine it released GH without significantly raising ACTH or cortisol, unlike GHRP-6 and GHRP-2 [1].

What is the difference between ipamorelin and CJC-1295?

Ipamorelin is a GHRP-receptor agonist; CJC-1295 is an analog of growth hormone-releasing hormone (GHRH), which acts on a different receptor.

Is ipamorelin FDA-approved?

No. FDA lists ipamorelin acetate in Category 2 [3].

Research materials and certificates

References

  1. Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-61. doi:10.1530/eje.0.1390552. PMID: 9849822
  2. Johansen PB, Nowak J, Skjaerbaek C, et al. Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats. Growth Horm IGF Res. 1999;9(2):106-13. doi:10.1054/ghir.1999.9998. PMID: 10373343
  3. U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (Category 2). Content current as of 04/22/2026. fda.gov

Research-use-only disclaimer: All products from My Freedom Peptides are supplied as a lyophilized powder for laboratory research. They are for research use only and not for human or veterinary use. My Freedom Peptides LLC is a chemical supplier. It is not a 503A compounding pharmacy or a 503B outsourcing facility. These statements have not been evaluated by the Food and Drug Administration. Products are not intended to diagnose, treat, cure, or prevent any disease.